{"transactions":[{"id":1453569,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-16T16:24:08.000Z","date":"2024-07-12","kind":"exercise","planned":true,"acquired":false,"shares":6525,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6525,"derivative":{"exercise_price":3.26,"exercise_date":"2024-01-06","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":6525},"source":{"system":"sec-edgar","filing":"0001562180-24-005752","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024005752/primarydocument.xml","form_type":"4"}},{"id":1453568,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-16T16:24:08.000Z","date":"2024-07-12","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3250,"derivative":{"exercise_price":3.5,"exercise_date":"2024-02-23","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001562180-24-005752","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024005752/primarydocument.xml","form_type":"4"}},{"id":1453567,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-16T16:24:08.000Z","date":"2024-07-12","kind":"sale","planned":true,"acquired":false,"shares":11625,"price":10.0641,"value":116995.1625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.125. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of  EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1850,"source":{"system":"sec-edgar","filing":"0001562180-24-005752","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024005752/primarydocument.xml","form_type":"4"}},{"id":1453566,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-16T16:24:08.000Z","date":"2024-07-12","kind":"exercise","planned":true,"acquired":true,"shares":6525,"price":3.26,"value":21271.5,"ownership":{"direct":true},"balance_after":13475,"source":{"system":"sec-edgar","filing":"0001562180-24-005752","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024005752/primarydocument.xml","form_type":"4"}},{"id":1453565,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-16T16:24:08.000Z","date":"2024-07-12","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":3.5,"value":11375.0,"ownership":{"direct":true},"balance_after":6950,"source":{"system":"sec-edgar","filing":"0001562180-24-005752","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024005752/primarydocument.xml","form_type":"4"}},{"id":1491725,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-04T16:28:51.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":false,"shares":6525,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13050,"derivative":{"exercise_price":3.26,"exercise_date":"2024-01-06","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":6525},"source":{"system":"sec-edgar","filing":"0001562180-24-004638","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004638/primarydocument.xml","form_type":"4"}},{"id":1491724,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-04T16:28:51.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6500,"derivative":{"exercise_price":3.5,"exercise_date":"2024-02-23","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001562180-24-004638","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004638/primarydocument.xml","form_type":"4"}},{"id":1491723,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T16:28:51.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":11625,"price":10.2972,"value":119704.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.87. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of  EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":3700,"source":{"system":"sec-edgar","filing":"0001562180-24-004638","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004638/primarydocument.xml","form_type":"4"}},{"id":1491722,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T16:28:51.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":3.5,"value":11375.0,"ownership":{"direct":true},"balance_after":15325,"source":{"system":"sec-edgar","filing":"0001562180-24-004638","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004638/primarydocument.xml","form_type":"4"}},{"id":1491721,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T16:28:51.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":true,"shares":6525,"price":3.26,"value":21271.5,"ownership":{"direct":true},"balance_after":12075,"source":{"system":"sec-edgar","filing":"0001562180-24-004638","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004638/primarydocument.xml","form_type":"4"}},{"id":1513978,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-16T17:19:51.000Z","date":"2024-05-14","kind":"exercise","planned":true,"acquired":false,"shares":6525,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19575,"derivative":{"exercise_price":3.26,"exercise_date":"2024-01-06","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":6525},"source":{"system":"sec-edgar","filing":"0001562180-24-004106","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004106/primarydocument.xml","form_type":"4"}},{"id":1513977,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-16T17:19:51.000Z","date":"2024-05-14","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9750,"derivative":{"exercise_price":3.5,"exercise_date":"2024-02-23","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001562180-24-004106","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004106/primarydocument.xml","form_type":"4"}},{"id":1513976,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T17:19:51.000Z","date":"2024-05-14","kind":"sale","planned":true,"acquired":false,"shares":11625,"price":12.649,"value":147044.625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.44 to $12.83. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of  EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5550,"source":{"system":"sec-edgar","filing":"0001562180-24-004106","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004106/primarydocument.xml","form_type":"4"}},{"id":1513975,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T17:19:51.000Z","date":"2024-05-14","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":3.5,"value":11375.0,"ownership":{"direct":true},"balance_after":17175,"source":{"system":"sec-edgar","filing":"0001562180-24-004106","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004106/primarydocument.xml","form_type":"4"}},{"id":1513974,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T17:19:51.000Z","date":"2024-05-14","kind":"exercise","planned":true,"acquired":true,"shares":6525,"price":3.26,"value":21271.5,"ownership":{"direct":true},"balance_after":13925,"source":{"system":"sec-edgar","filing":"0001562180-24-004106","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024004106/primarydocument.xml","form_type":"4"}},{"id":1682461,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-09T20:56:10.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":25014,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25014,"derivative":{"exercise_price":20.4,"exercise_date":"2025-01-05","expiration_date":"2034-01-04","underlying":"Common Stock","underlying_shares":25014},"source":{"system":"sec-edgar","filing":"0001562180-24-000396","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218024000396/primarydocument.xml","form_type":"4"}},{"id":1846291,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-22T09:22:02.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13000,"derivative":{"exercise_price":3.5,"exercise_date":"2024-02-23","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001562180-23-005451","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218023005451/primarydocument.xml","form_type":"4"}},{"id":1846290,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-22T09:22:02.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26100,"derivative":{"exercise_price":3.26,"exercise_date":"2024-01-06","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001562180-23-005451","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218023005451/primarydocument.xml","form_type":"4"}},{"id":2019565,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-13T17:08:38.000Z","date":"2023-02-09","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested on the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested on the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001562180-23-001338","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218023001338/primarydocument.xml","form_type":"4"}},{"id":2019564,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T17:08:38.000Z","date":"2023-02-09","kind":"exercise","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7400,"source":{"system":"sec-edgar","filing":"0001562180-23-001338","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218023001338/primarydocument.xml","form_type":"4"}},{"id":2401226,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-11T16:54:08.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":10.13,"exercise_date":"2023-02-09","expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001562180-22-001419","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218022001419/primarydocument.xml","form_type":"4"}},{"id":2401225,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-11T16:54:08.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will fully vest on the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Will fully vest on the one-year anniversary of the grant date."}],"balance_after":3000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001562180-22-001419","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218022001419/primarydocument.xml","form_type":"4"}},{"id":2401224,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-11T16:54:08.000Z","date":"2022-02-09","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested on the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested on the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001562180-22-001419","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218022001419/primarydocument.xml","form_type":"4"}},{"id":2401223,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T16:54:08.000Z","date":"2022-02-09","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4400,"source":{"system":"sec-edgar","filing":"0001562180-22-001419","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218022001419/primarydocument.xml","form_type":"4"}},{"id":2656905,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T17:30:58.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11000,"derivative":{"exercise_price":13.13,"exercise_date":"2022-02-09","expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001562180-21-004458","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218021004458/primarydocument.xml","form_type":"4"}},{"id":2656904,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-23T17:30:58.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Will fully vest on the one-year anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":0,"exercise_date":"2022-02-09","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001562180-21-004458","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218021004458/primarydocument.xml","form_type":"4"}},{"id":2819290,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-03-02T19:22:09.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested on the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-02-28","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0001562180-21-001815","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218021001815/primarydocument.xml","form_type":"4"}},{"id":2819289,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-02T19:22:09.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1900,"source":{"system":"sec-edgar","filing":"0001562180-21-001815","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218021001815/primarydocument.xml","form_type":"4"}},{"id":2934467,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-12-22T17:49:01.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":102630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":102630,"derivative":{"underlying":"Common Stock","underlying_shares":102630},"source":{"system":"sec-edgar","filing":"0001104659-20-138669","document":"tm2039210-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920138669/tm2039210-1_4.xml","form_type":"4"}},{"id":2934466,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-22T17:49:01.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":205150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest as follows: (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the \"Performance Condition\"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in equal monthly installments through the fourth anniversary of the grant date, and (3) such stock option shall be subject to \"double-trigger\" acceleration of vesting upon termination of employment following a change in control of the Registrant."}],"balance_after":205150,"derivative":{"exercise_price":7.5,"expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":205150},"source":{"system":"sec-edgar","filing":"0001104659-20-138669","document":"tm2039210-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920138669/tm2039210-1_4.xml","form_type":"4"}},{"id":2944252,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-12-15T14:48:19.000Z","date":"2020-12-12","kind":"exercise","acquired":false,"shares":17200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On December 12, 2018, the Reporting Person was granted 68,800 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions of the Registrant's 2013 Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On December 12, 2018, the Reporting Person was granted 68,800 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions of the Registrant's 2013 Stock Incentive Plan."}],"balance_after":34400,"derivative":{"underlying":"Common Stock","underlying_shares":17200},"source":{"system":"sec-edgar","filing":"0001104659-20-135677","document":"tm2038552-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920135677/tm2038552-3_4.xml","form_type":"4"}},{"id":2944251,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-12-15T14:48:19.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":9270,"price":7.16,"value":66373.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $6.98 to $7.34 on December 14, 2020 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range."}],"balance_after":70113,"source":{"system":"sec-edgar","filing":"0001104659-20-135677","document":"tm2038552-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920135677/tm2038552-3_4.xml","form_type":"4"}},{"id":2944250,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-12-15T14:48:19.000Z","date":"2020-12-12","kind":"exercise","acquired":true,"shares":17200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":79383,"source":{"system":"sec-edgar","filing":"0001104659-20-135677","document":"tm2038552-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920135677/tm2038552-3_4.xml","form_type":"4"}},{"id":2948472,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-12-11T20:59:09.000Z","date":"2020-12-09","kind":"grant","acquired":false,"shares":17813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On December 9, 2019, the Reporting Person was granted an award of 71,250 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On December 9, 2019, the Reporting Person was granted an award of 71,250 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."}],"balance_after":53437,"derivative":{"underlying":"Common Stock","underlying_shares":17813},"source":{"system":"sec-edgar","filing":"0001104659-20-134929","document":"tm2038354-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920134929/tm2038354-1_4seq1.xml","form_type":"4"}},{"id":2948471,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-12-11T20:59:09.000Z","date":"2020-12-10","kind":"sale","acquired":false,"shares":9602,"price":6.96,"value":66829.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $6.83 to $7.05 on December 10, 2020 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range."}],"balance_after":62183,"source":{"system":"sec-edgar","filing":"0001104659-20-134929","document":"tm2038354-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920134929/tm2038354-1_4seq1.xml","form_type":"4"}},{"id":2948470,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-12-11T20:59:09.000Z","date":"2020-12-09","kind":"exercise","acquired":true,"shares":17813,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":71785,"source":{"system":"sec-edgar","filing":"0001104659-20-134929","document":"tm2038354-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920134929/tm2038354-1_4seq1.xml","form_type":"4"}},{"id":3231386,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-03T18:25:01.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33500,"derivative":{"exercise_price":1.29,"exercise_date":"2021-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001562180-20-002051","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218020002051/primarydocument.xml","form_type":"4"}},{"id":3231385,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-03T18:25:01.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Will fully vest on the one-year anniversary of the grant date."}],"balance_after":19000,"derivative":{"exercise_price":0,"exercise_date":"2021-02-28","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001562180-20-002051","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218020002051/primarydocument.xml","form_type":"4"}},{"id":3316199,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-01-07T19:31:31.000Z","date":"2020-01-04","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 4, 2016, the Reporting Person was granted an award of 25,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 4, 2016, the Reporting Person was granted an award of 25,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001104659-20-002077","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920002077/a4.xml","form_type":"4"}},{"id":3316198,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-01-07T19:31:31.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":3367,"price":8.07,"value":27171.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on January 4, 2020."}],"balance_after":53972,"source":{"system":"sec-edgar","filing":"0001104659-20-002077","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920002077/a4.xml","form_type":"4"}},{"id":3316197,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-01-07T19:31:31.000Z","date":"2020-01-04","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":57339,"source":{"system":"sec-edgar","filing":"0001104659-20-002077","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920002077/a4.xml","form_type":"4"}},{"id":3340794,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-12-16T17:25:31.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":17200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 12, 2018, the Reporting Person was granted 68,800 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions of the Registrant's 2013 Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 12, 2018, the Reporting Person was granted 68,800 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions of the Registrant's 2013 Stock Incentive Plan."}],"balance_after":51600,"derivative":{"underlying":"Common Stock","underlying_shares":17200},"source":{"system":"sec-edgar","filing":"0001104659-19-073113","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919073113/a4.xml","form_type":"4"}},{"id":3340793,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-12-16T17:25:31.000Z","date":"2019-12-13","kind":"sale","acquired":false,"shares":9275,"price":6.6,"value":61215.0,"ownership":{"direct":true},"balance_after":51089,"source":{"system":"sec-edgar","filing":"0001104659-19-073113","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919073113/a4.xml","form_type":"4"}},{"id":3340792,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-12-16T17:25:31.000Z","date":"2019-12-12","kind":"exercise","acquired":true,"shares":17200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":60364,"source":{"system":"sec-edgar","filing":"0001104659-19-073113","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919073113/a4.xml","form_type":"4"}},{"id":3345095,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-12-11T18:54:22.000Z","date":"2019-12-09","kind":"grant","acquired":true,"shares":71250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":71250,"derivative":{"underlying":"Common Stock","underlying_shares":71250},"source":{"system":"sec-edgar","filing":"0001104659-19-071930","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919071930/a4.xml","form_type":"4"}},{"id":3345094,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-11T18:54:22.000Z","date":"2019-12-09","kind":"grant","acquired":true,"shares":142500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest as follows:  (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the \"Performance Condition\"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in equal monthly installments through the fourth anniversary of the grant date, and (3) such stock option shall be subject to \"double-trigger\" acceleration of vesting upon termination of employment following a change in control of the Registrant."}],"balance_after":142500,"derivative":{"exercise_price":5.22,"expiration_date":"2029-12-08","underlying":"Common Stock","underlying_shares":142500},"source":{"system":"sec-edgar","filing":"0001104659-19-071930","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919071930/a4.xml","form_type":"4"}},{"id":3683639,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-29T16:08:31.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in three equal annual installments beginning on January 25, 2020."}],"balance_after":80000,"derivative":{"exercise_price":2.42,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-19-000563","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277476/000156218019000563/primarydocument.xml","form_type":"4"}},{"id":3701790,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-01-07T20:34:51.000Z","date":"2019-01-04","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 4, 2016, the reporting person was granted an award of 25,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan."}],"balance_after":6250,"derivative":{"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001104659-19-001169","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919001169/a4.xml","form_type":"4"}},{"id":3701789,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-01-07T20:34:51.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":3859,"price":1.3,"value":5016.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on January 4, 2019."}],"balance_after":43164,"source":{"system":"sec-edgar","filing":"0001104659-19-001169","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919001169/a4.xml","form_type":"4"}},{"id":3701788,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-01-07T20:34:51.000Z","date":"2019-01-04","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":47023,"source":{"system":"sec-edgar","filing":"0001104659-19-001169","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919001169/a4.xml","form_type":"4"}},{"id":3703741,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-01-04T18:26:25.000Z","date":"2019-01-02","kind":"exercise","acquired":false,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 2, 2015, the reporting person was granted an award of 23,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan."}],"balance_after":0,"derivative":{"expiration_date":"2025-01-01","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001104659-19-000888","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919000888/a4.xml","form_type":"4"}},{"id":3703740,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-01-04T18:26:25.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":3637,"price":1.24,"value":4509.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on January 2, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were disposed of in multiple transactions on January 3, 2019 at actual sales prices ranging from $1.23 to $1.25 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":40773,"source":{"system":"sec-edgar","filing":"0001104659-19-000888","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919000888/a4.xml","form_type":"4"}},{"id":3703739,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-01-04T18:26:25.000Z","date":"2019-01-02","kind":"exercise","acquired":true,"shares":5750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":44410,"source":{"system":"sec-edgar","filing":"0001104659-19-000888","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919000888/a4.xml","form_type":"4"}},{"id":3730578,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2018-12-14T17:15:09.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":68800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":68800,"derivative":{"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":68800},"source":{"system":"sec-edgar","filing":"0001104659-18-073133","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918073133/a4.xml","form_type":"4"}},{"id":3730577,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-14T17:15:09.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":137500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, each of these stock option awards will vest as follows: (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the \"Performance Condition\"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date, and (3) such stock option shall be subject to \"double-trigger\" acceleration of vesting upon termination of employment following a change in control of the Registrant."}],"balance_after":137500,"derivative":{"exercise_price":1.45,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":137500},"source":{"system":"sec-edgar","filing":"0001104659-18-073133","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918073133/a4.xml","form_type":"4"}},{"id":4105327,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2018-01-05T17:21:08.000Z","date":"2018-01-04","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 4, 2016, the reporting person was granted an award of 25,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan."}],"balance_after":12500,"derivative":{"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001104659-18-001012","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918001012/a4.xml","form_type":"4"}},{"id":4105326,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-05T17:21:08.000Z","date":"2018-01-05","kind":"sale","acquired":false,"shares":3798,"price":3.17,"value":12039.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on January 4, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were disposed of in multiple transactions on January 5, 2018 at actual sales prices ranging from $3.16 to $3.19 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":38660,"source":{"system":"sec-edgar","filing":"0001104659-18-001012","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918001012/a4.xml","form_type":"4"}},{"id":4105325,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-05T17:21:08.000Z","date":"2018-01-04","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":42458,"source":{"system":"sec-edgar","filing":"0001104659-18-001012","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918001012/a4.xml","form_type":"4"}},{"id":4107295,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2018-01-04T17:13:47.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 2, 2015, the reporting person was granted an award of 23,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan."}],"balance_after":5750,"derivative":{"expiration_date":"2025-01-01","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001104659-18-000812","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918000812/a4.xml","form_type":"4"}},{"id":4107294,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-04T17:13:47.000Z","date":"2018-01-03","kind":"sale","acquired":false,"shares":3516,"price":3.24,"value":11391.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on January 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were disposed of in multiple transactions on January 3, 2018 at actual sales prices ranging from $3.24 to $3.25 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":36208,"source":{"system":"sec-edgar","filing":"0001104659-18-000812","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918000812/a4.xml","form_type":"4"}},{"id":4107293,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-04T17:13:47.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":5750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":39724,"source":{"system":"sec-edgar","filing":"0001104659-18-000812","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918000812/a4.xml","form_type":"4"}},{"id":4111336,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2018-01-03T17:00:37.000Z","date":"2017-12-29","kind":"exercise","acquired":false,"shares":30480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 17, 2017, the reporting person was granted an award of 60,960 restricted stock units, which vested with respect to 50% of the shares subject to the award on each of June 30, 2017 and December 29, 2017, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan."}],"balance_after":0,"derivative":{"expiration_date":"2027-01-16","underlying":"Common Stock","underlying_shares":30480},"source":{"system":"sec-edgar","filing":"0001104659-18-000565","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918000565/a4.xml","form_type":"4"}},{"id":4111335,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-03T17:00:37.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":16520,"price":3.19,"value":52698.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on December 29, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were disposed of in multiple transactions on January 2, 2018 at actual sales prices ranging from $3.10 to $3.25 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":33974,"source":{"system":"sec-edgar","filing":"0001104659-18-000565","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918000565/a4.xml","form_type":"4"}},{"id":4111334,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-03T17:00:37.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":30480,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":50494,"source":{"system":"sec-edgar","filing":"0001104659-18-000565","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918000565/a4.xml","form_type":"4"}},{"id":4123532,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-21T17:08:12.000Z","date":"2017-12-19","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, each of these stock option awards will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date."}],"balance_after":300000,"derivative":{"exercise_price":2.94,"expiration_date":"2027-12-18","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-17-074631","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917074631/a4.xml","form_type":"4"}},{"id":4264005,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2017-07-05T18:34:41.000Z","date":"2017-06-30","kind":"exercise","acquired":false,"shares":30480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 17, 2017, the reporting person was granted an award of 60,960 restricted stock units, which vests with respect to 50% of the shares subject to the award on each of June 30, 2017 and December 29, 2017, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan."}],"balance_after":30480,"derivative":{"expiration_date":"2027-01-16","underlying":"Common Stock","underlying_shares":30480},"source":{"system":"sec-edgar","filing":"0001104659-17-043659","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917043659/a4.xml","form_type":"4"}},{"id":4264004,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-07-05T18:34:41.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":17678,"price":2.58,"value":45609.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on June 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were disposed of in multiple transactions on July 5, 2017 at actual sales prices ranging from $2.55 to $2.64 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":20014,"source":{"system":"sec-edgar","filing":"0001104659-17-043659","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917043659/a4.xml","form_type":"4"}},{"id":4264003,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-07-05T18:34:41.000Z","date":"2017-06-30","kind":"exercise","acquired":true,"shares":30480,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":37692,"source":{"system":"sec-edgar","filing":"0001104659-17-043659","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917043659/a4.xml","form_type":"4"}},{"id":4473402,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-01T17:14:31.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, each of these stock option awards will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date."}],"balance_after":260000,"derivative":{"exercise_price":4.52,"expiration_date":"2027-01-29","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001104659-17-005852","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917005852/a4.xml","form_type":"4"}},{"id":4486428,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-19T17:36:16.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":60960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan and the reporting person's employment agreement, the award of restricted stock units will vest with respect to 50% of the shares subject to the award on each of June 30, 2017 and December 29, 2017."}],"balance_after":60960,"derivative":{"expiration_date":"2027-01-16","underlying":"Common Stock","underlying_shares":60960},"source":{"system":"sec-edgar","filing":"0001104659-17-003127","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917003127/a4.xml","form_type":"4"}},{"id":4496242,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T17:14:12.000Z","date":"2017-01-04","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 4, 2016, the reporting person was granted an award of 25,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan."}],"balance_after":18750,"derivative":{"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001104659-17-001233","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917001233/a4.xml","form_type":"4"}},{"id":4496241,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-06T17:14:12.000Z","date":"2017-01-05","kind":"sale","acquired":false,"shares":3785,"price":4.96,"value":18773.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on January 4, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were disposed of in multiple transactions on January 5, 2017 at actual sales prices ranging from $4.90 to $5.04 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7212,"source":{"system":"sec-edgar","filing":"0001104659-17-001233","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917001233/a4.xml","form_type":"4"}},{"id":4496240,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-06T17:14:12.000Z","date":"2017-01-04","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":10997,"source":{"system":"sec-edgar","filing":"0001104659-17-001233","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917001233/a4.xml","form_type":"4"}},{"id":4502395,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-04T17:06:11.000Z","date":"2017-01-02","kind":"exercise","acquired":false,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 2, 2015, the reporting person was granted an award of 23,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan."}],"balance_after":11500,"derivative":{"expiration_date":"2025-01-01","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001104659-17-000647","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917000647/a4.xml","form_type":"4"}},{"id":4502394,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-04T17:06:11.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":3484,"price":4.9,"value":17071.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on January 2, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were disposed of in multiple transactions on January 3, 2017 at actual sales prices ranging from $4.85 to $4.98 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4747,"source":{"system":"sec-edgar","filing":"0001104659-17-000647","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917000647/a4.xml","form_type":"4"}},{"id":4502393,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-04T17:06:11.000Z","date":"2017-01-02","kind":"exercise","acquired":true,"shares":5750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":8231,"source":{"system":"sec-edgar","filing":"0001104659-17-000647","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465917000647/a4.xml","form_type":"4"}},{"id":4567592,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-11-03T21:35:34.000Z","date":"2016-11-01","kind":"exercise","acquired":false,"shares":22060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Represents the aggregate number of options remaining from each of two awards that were granted to the Reporting Person on April 26, 2013, each of which has an expiration date of April 25, 2023 and an exercise price of $10.03 per option. These two awards were previously reported separately by the Reporting Person."}],"balance_after":105636,"derivative":{"exercise_price":10.03,"expiration_date":"2023-04-25","underlying":"Common Stock","underlying_shares":22060},"source":{"system":"sec-edgar","filing":"0001104659-16-154726","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916154726/a4.xml","form_type":"4"}},{"id":4567591,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-11-03T21:35:34.000Z","date":"2016-11-01","kind":"sale","acquired":false,"shares":3820,"price":36.86,"value":140805.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were disposed of in multiple transactions on November 1, 2016 at actual sales prices ranging from $36.41 to $37.305 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2481,"source":{"system":"sec-edgar","filing":"0001104659-16-154726","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916154726/a4.xml","form_type":"4"}},{"id":4567590,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-11-03T21:35:34.000Z","date":"2016-11-01","kind":"sale","acquired":false,"shares":7710,"price":35.93,"value":277020.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were disposed of in multiple transactions on November 1, 2016 at actual sales prices ranging from $35.41 to $36.40 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6301,"source":{"system":"sec-edgar","filing":"0001104659-16-154726","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916154726/a4.xml","form_type":"4"}},{"id":4567589,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-11-03T21:35:34.000Z","date":"2016-11-01","kind":"sale","acquired":false,"shares":10530,"price":34.93,"value":367812.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were disposed of in multiple transactions on November 1, 2016 at actual sales prices ranging from $34.38 to $35.32 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":14011,"source":{"system":"sec-edgar","filing":"0001104659-16-154726","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916154726/a4.xml","form_type":"4"}},{"id":4567588,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-11-03T21:35:34.000Z","date":"2016-11-01","kind":"exercise","acquired":true,"shares":22060,"price":10.03,"value":221261.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015."}],"balance_after":24541,"source":{"system":"sec-edgar","filing":"0001104659-16-154726","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916154726/a4.xml","form_type":"4"}},{"id":4584239,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-10-05T17:16:53.000Z","date":"2016-10-03","kind":"exercise","acquired":false,"shares":16210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017."}],"balance_after":8334,"derivative":{"exercise_price":10.03,"expiration_date":"2023-04-25","underlying":"Common Stock","underlying_shares":16210},"source":{"system":"sec-edgar","filing":"0001104659-16-148935","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916148935/a4.xml","form_type":"4"}},{"id":4584238,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-10-05T17:16:53.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":1600,"price":45.97,"value":73552.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were disposed of in multiple transactions on October 3, 2016 at actual sales prices ranging from $45.355  to $46.22 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2481,"source":{"system":"sec-edgar","filing":"0001104659-16-148935","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916148935/a4.xml","form_type":"4"}},{"id":4584237,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-10-05T17:16:53.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":6632,"price":44.77,"value":296914.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were disposed of in multiple transactions on October 3, 2016 at actual sales prices ranging from $44.39  to $45.28 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4081,"source":{"system":"sec-edgar","filing":"0001104659-16-148935","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916148935/a4.xml","form_type":"4"}},{"id":4584236,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-10-05T17:16:53.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":13828,"price":44,"value":608432.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were disposed of in multiple transactions on October 3, 2016 at actual sales prices ranging from $43.39  to $44.38 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10713,"source":{"system":"sec-edgar","filing":"0001104659-16-148935","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916148935/a4.xml","form_type":"4"}},{"id":4584235,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-10-05T17:16:53.000Z","date":"2016-10-03","kind":"exercise","acquired":true,"shares":16210,"price":10.03,"value":162586.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015."}],"balance_after":24541,"source":{"system":"sec-edgar","filing":"0001104659-16-148935","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916148935/a4.xml","form_type":"4"}},{"id":4610965,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88941,"kind":"person","name":"GUYER DAVID R","position":1,"cik":"0001277476","reported_name":"GUYER DAVID R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-09-06T17:15:32.000Z","date":"2016-09-01","kind":"sale","acquired":false,"shares":24060,"price":52.58,"value":1265074.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were disposed of in multiple transactions on September 1, 2016 at actual sales prices ranging from $52.385  to $53.00 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":8331,"source":{"system":"sec-edgar","filing":"0001104659-16-143256","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465916143256/a4.xml","form_type":"4"}}]}